Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$25.39 - $42.1 $279 - $463
11 New
11 $0
Q4 2023

Jan 31, 2024

BUY
$28.47 - $38.49 $1,252 - $1,693
44 New
44 $1,000
Q2 2023

Jul 28, 2023

BUY
$17.67 - $31.31 $70 - $125
4 Added 57.14%
11 $0
Q4 2022

Jan 24, 2023

SELL
$29.44 - $37.31 $5,122 - $6,491
-174 Reduced 96.13%
7 $0
Q3 2022

Nov 10, 2022

BUY
$28.84 - $38.92 $5,018 - $6,772
174 Added 2485.71%
181 $6,000
Q3 2020

Nov 03, 2020

SELL
$37.98 - $48.72 $569 - $730
-15 Reduced 68.18%
7 $0
Q4 2018

Feb 07, 2019

BUY
$44.93 - $73.38 $988 - $1,614
22 New
22 $1,000

Others Institutions Holding SRDX

About SURMODICS INC


  • Ticker SRDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,005,000
  • Market Cap $477M
  • Description
  • Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...
More about SRDX
Track This Portfolio

Track Lindbrook Capital, LLC Portfolio

Follow Lindbrook Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.